The CCTS Investigator
Accelerating Discoveries Toward Better Health
|
|
Last week marked the one year anniversary of the first confirmed case of COVID-19. Few of us could have imagined the unprecedented impact that this pandemic would ultimately have on our lives, our communities, the nation and the world.
As the waves of uncertainty and the need for social distancing challenged our ability to engage in clinical and translational science, the scientific community rose to the occasion.
We developed innovative new methods and efficiencies that transformed our ability to combat this pandemic and advance all areas of science.
We have pushed the current boundaries of team science and collaboration, incorporated digital strategies and promoted the rapid sharing of data and ideas while creating new methods to enhance safety and efficiency.
We have done this while preserving the rigor and reproducibility of our work. We embraced the concepts of protect and pivot - staying true to our fundamental mission to translate scientific discoveries to improve health while pivoting to find ways to thrive in this new environment.
At the 2020 CCTS Annual Scientific Meeting and in workshops such as our monthly COVID-19 Inventor Showcase we have highlighted just a small number of the incredible advances in translational science here at Ohio State and across the CTSA Consortium as we learn from the successes and challenges faced by our colleagues in the last year.
Those stars reflect the thousands of discoveries ranging from fundamental science to clinical research and ways we can bring the voices of our communities to the table in translational science to ensure equity and inclusion that will shape our scientific world for years to come.
May these 1,000 points of light provide you some ideas and resources to support your own work.
Rebecca Jackson MD
Director, OSU Center for Clinical and Translational Science
|
|
OSU CCTS is proud to announce the 2020 Annual Scientific Meeting Poster winners.
|
|
The Office of Research invites self-nominations from all colleges to a new leadership development program: the Growing Research Opportunities (GRO) Academy.
This program will equip faculty with the skills needed to lead complex, interdisciplinary collaborations in pursuit of external funding. The GRO Academy is part of a developing set of multi-faceted programs designed to foster intellectually diverse, collaborative research across academic domains, catalyze new scholarly pursuits, and help generate compelling future funding proposals.
|
|
Researchers planning COVID-19 trials with the Trial Innovation Network (TIN) can leverage the N3C to inform their research hypotheses. N3C focuses on aligning its infrastructure so that it can generate efficient and minimally biased results. Part of that infrastructure includes the curation of value sets and phenotype variables relevant to COVID-19, such as ventilator support, ICU use, and definitions of COVID-19 cases. The potential impact of having clinical study data available from a large-scale harmonized observational database is significant.
This webinar will provide an overview and update on the status of N3C, followed by presentations from 3 of the 21 N3C Domain Teams on how they can inform clinical trial protocol development: Pharma-Commercial, Pharmacoepidemiology, Social Determinants of Health.
When: February 1st, 2021
Where: Online
|
|
Whereas our drug session covered all information in a single 2-hour webinar, we have made changes to the medical device session to better deliver the information, increase flexibility, and make the most efficient use of attendees' time.
First, we will provide a regulatory overview of medical device research via an online recording, accessible in January 2021, and the second part will be presented live via Zoom on Tuesday, February 2, 2021.
All registered individuals will be provided a link to the recording once available, and it should be viewed prior to the February Zoom session, which will focus on practical application.
When: February 2nd, 2021, 9:00 AM - 10:30 AM
Where: Online
|
|
In this series, accomplished leaders provide insights into intangible attributes that have led to career success. In this program, Dr. William Carson, professor of Surgery and Associate Director for Clinical Research, OSU Comprehensive Cancer Center provides ten tips for success to physicians engaged in academic medicine.
When: February 5th, 2021, 12:00 PM - 1:00 PM
Where: Online
|
|
The professional narrative is one of the most important if not the most important part of your dossier. This session will review how to write this narrative, which in many ways has the components of any well-told story, and illustrates how to emphasize to all who review the dossier the theme of your work and its importance. This is part one of our Everything P&T series, please register for each session individually, you do not need to attend every session.
When: February 8th, 2021, 3:00 - 4:30 PM
Where: Online
|
|
Kristen Heitman, MS, RDN, LD, with the Center for Clinical Research Management will be addressing research studies involving nutritional components, as well as new NIH initiatives.
When: February 11th, 2021, 9:00 AM - 10:00 AM
Where: Online
|
|
In 2016, the NIH designated gender and sexual minorities an official health disparity population. This is a welcome change that increases research attention and possible funding opportunities to work with LGBTQI communities. However, more research opportunities do not necessarily translate to better research. This panel will discuss the distinctive challenges of research concerning gender and sexual minorities, including the risks of research fatigue, prioritization of research, stigma, trust, and community empowerment.
When: February 16th, 2021, 12:00 PM - 1:00 PM
Where: Online
|
|
Presented by the CCTS Optimizing Innovation, Commercialization and Entrepreneurship of Biomedical Research Program in partnership with the Corporate Engagement Office and Nationwide Children’s Hospital’s Office of Technology Commercialization, this monthly panel webinar series highlights experts working together to fight against COVID-19 on the front lines of innovation.
The novel coronavirus, SARS-CoV-2, spreads easily from person to person. Understanding how long the virus can stay alive on indoor surfaces or in the air can help prevent transmission.
Learn how an interdisciplinary team from Ohio State and University of Notre Dame have developed novel indoor monitoring techniques to help prevent exposure to the virus.
Noon-1 p.m.
When: February 16th, 2021, 12:00 PM - 1:00 PM
Where: Online
|
|
The Biostatistics, Epidemiology, and Research Design (BERD) program announces the Secondary Data Analysis (SDA) Seminar Series: Rethink, Reuse, Research. The goals of the seminar series are:
1. Education: To educate investigators about existing data and how that data can be used for research.
2. Collaboration: To partner with investigators interested in performing SDA and assist them in developing successful research proposals.
3. Promotion: To increase awareness and visibility of CCTS/BERD members and resources.
After attending this seminar series, participants should be able to:
- Recognize BERD and its members/subgroups and describe how they work as collaborative research partners.
- For each dataset discussed in the series:
- Understand the background and overview of the original study design.
- Identify the types of data contained in dataset.
- Describe examples of previous research that have been used.
- Identify major limitations of practical issues in working with data that must be taken into consideration for research.
- Understand the process to access data and identify BERD member(s) to collaborate with for research.
When: February 18th, 2021, 12:00 PM - 1:00 PM
Where: Online
|
|
This session delves into all aspects of the promotion system including national reputation, demonstrating impact, and writing a dossier. This is part two of our Everything P&T series, please register for each session individually, you do not need to attend every session.
When: March 2nd, 2021, 9:00 AM - 10:30 AM
Where: Online
|
|
IPR offers seed grants to nurture research projects consistent with IPR's mission to promote population science research. IPR favors multi-disciplinary collaboration. We especially encourage applications from junior faculty, and from faculty new to population and health research.
Deadline: March 3rd, 2021
|
|
Are you interested in moving your technology out of the lab and into the market? Apply for a $12,500 grant to participate in the 2021 I-Corps@Ohio technology commercialization training program.
Through this grant-funded program, selected participants will:
• learn key business modeling concepts and their relevance to startup efforts
• assess their core assumptions by testing hypotheses
• conduct numerous interviews with customers about market needs
• learn from executive mentors and certified instructors with relevant industry, scientific and startup experiences
Deadline: February 1, 2021
|
|
Funding Opportunities from the NIH.
|
|
In conjunction with the CCTS Recruitment and Retention Office, NCH researchers can now request recruitment and retention consultation services here.
|
|
|
|
Read about the latest translational science news, opportunities, and announcements in the latest edition of the NCATS e-Newsletter and the NIH's Weekly Funding Notice.
|
Learn more about PCORI through their blog, video room, news releases, and other resources.
|
|
ResearchMatch brings together people who are trying to find research studies and clinical trials, and researchers who are looking for volunteers.
- ResearchMatch is a national volunteer registry that researchers at OSU can use to find potential volunteers at no cost.
- ResearchMatch is an effective, useful and complementary recruitment tool that will help connect willing volunteers with researchers who are searching for appropriate volunteers to be placed in their research studies.
|
|
Stay Up To Date With The CCTS! |
|
|
Publications supported by the OSU CCTS are required to cite the OSU CCTS.
|
|
|
|
|
|
|
|
